Asia Pacific Healthcare Outlook 2012-2015: What comes next..

Manage webcast
Reenita Das, Senior Vice President Healthcare and Lifesciences, Frost & Sullivan
The Healthcare industry is undergoing a rapid transformation with a number of macro trends colliding together such as mobility, internet, consolidation, patient empowerment, global pandemics, aging population, evidence based medicine, prevention, medical tourism, etc. to create business model changes. These trends are altering the way Healthcare is implemented and delivered.

This briefing will focus on the outlook for Asia Pacific with respect to these business model changes in pharmaceuticals, devices, diagnostics and Healthcare Information Technology and highlight growth opportunities for 2012 and beyond.
Dec 8 2011
12 mins
Asia Pacific Healthcare Outlook 2012-2015: What comes next..
More from this community:

Health IT

  • Live and recorded (1000)
  • Upcoming (20)
  • Date
  • Rating
  • Views
  • Achieving your ADME/Tox testing goals requires experience, quality data, and proper alignment with regulatory guidance. Failure to meet these important requirements can put your drug discovery and pre-clinical goals at risk.
    This presentation will provide an informative overview of how you can advance and reach your pre-clinical drug discovery goals. It will discuss the importance of core contract research capabilities, including enzyme induction, enzyme inhibition, and transporter interaction. In addition, we will review new capabilities and opportunities including CYP induction and SLC transporter assay services – all designed to align with regulatory agency guidance documents.

    Speaker Bio:
    David Stresser is the Program Manager of Corning® Gentest℠ Contract Research Services at Corning Life Sciences since 2001, having held prior positions of Product Manager and Study Director since joining Corning in 1998. Prior to this, he was a post-doctoral associate in the laboratory of David Kupfer at the University of Massachusetts Medical School in Worcester, Massachusetts. He did his graduate work in the laboratory of David E. Williams at Oregon State University in Corvallis, Oregon receiving a Ph.D. in toxicology in 1994. Dr. Stresser has authored or co-authored 40 articles or book chapters in the field of drug metabolism and has been an invited speaker at various national and international meetings, pharmaceutical companies, and universities.
  • By now you've probably heard about new ransomware threats like CryptoWall, which encrypts your data and demands payment to unlock it. These threats are delivered via malicious email attachments or websites, and once they execute and connect to an external command and control server, they start to encrypt files throughout your network. Therefore, spotting infections quickly can limit the damage.

    AlienVault USM uses several built-in security controls working in unison to detect ransomware like CryptoWall, usually as soon as it attempts to connect to the hackers’ command and control server. How does it all work? Join us for a live demo that will show how AlienVault USM detects these threats quickly, saving you valuable clean up time by limiting the damage from the attack.
    You'll learn:
    How AlienVault USM detects communications with the command and control server
    How the behavior is correlated with other signs of trouble to alert you of the threat
    Immediate steps you need to take to stop the threat and limit the damage
  • Cell therapy is the fastest growing segment of regenerative medicine. Cell therapy is comprised of immune cell therapy and stem cell therapy, with stem cell therapy making up the largest part of this market: it is estimated that the global stem cell therapy market will reach $40 billion by 2020 and $180 billion by 2030.

    Many factors determine the rate at which the stem cell therapy market advances. It is driven by the success of stem cell treatments in curing life-threatening diseases such as cancer, heart diseases and neuromuscular diseases in the worlds aging populations. In contrast, stem cell market growth rate is hindered by manufacturing and regulatory concerns. For example, if only 20% of the 318 global late stage clinical trials are approved for release on the market, there will not be enough stem cell therapy manufacturing facilities to produce the 64 resulting products. This is due, in part, to funding concerns, the high cost of build-out as well as cGMP compliance, standardization of production processes, and ever changing industry regulations.

    Join us as we discuss these and other key topics.
  • The role of the CISO is evolving - and fast. CISOs today must find innovative ways to align with the business and strategize security as a top business asset -- and those that ascend in their role will have the opportunity to play a bigger, more influential role in the years to come. In this webinar hosted by Agari, you will hear Jim Routh, Aetna CISO share real world insights into specific challenges and solutions to approach today's evolving email threats as well as key 2018 CISO research from Chris McClean, Forrester VP of Research.
  • There are many decisions when choosing a video conferencing solution. Free versus subscription? Cloud solution or not? What type of video system is best suited for your meeting rooms? Join Gagan Verma, Regional Director of Lifesize, in this webinar where he will breakdown the top five considerations of video conferencing for 2015. Gagan will also elaborate on the competitive landscape and which solutions best fit your company’s needs.

    For enquiry: apac-mktg@lifesize.com or +65 6303 8379
  • Next to performance and scalability, cost efficiency is one of the top three reasons most companies cite as their motivations for acquiring storage technology. Businesses are struggling to control the storage costs, and to reduce OPEX costs for administrative staff, infrastructure and data management, and environmental and energy. Every storage vendor, it seems, including most of the Software-defined Storage purveyors, are promising ROIs that require nothing short of a suspension of disbelief.

    In this presentation, Jon Toigo of the Data Management Institute digs out the root causes of high storage costs and sketches out a prescription for addressing them. He is joined by Ibrahim “Ibby” Rahmani of DataCore Software, who will address the specific cost efficiency advantages that are being realized by customers of Software-defined Storage.
  • Wie Sie sicher wissen, untersagt das deutsche Bundesdatenschutzgesetz in seiner Zweckbindungsklausel das Verwenden von sensitiven Echtdaten in Test-, Entwicklungs- und Schulungssystemen. Dennoch sehen wir, dass eine Vielzahl von Unternehmen dieses Risiko immer noch eingeht und sich davor scheut, die nötigen Anpassungen durchzuführen.

    Die deutsche Versicherungswirtschaft begegnet diesem Thema mit dem Code of Conduct über den GDV als Vorreiter nun offensiv.

    Der GDV (Gesamtverband der deutschen Versicherer) ist der erste Verband in Deutschland, der für eine freiwillige Selbstverpflichtung zum Schutz von personenbezogenen Versichertendaten die Zustimmung der Datenschutzbehörden erhalten hat.

    Sämtliche deutschen Versicherungsunternehmen die dem Code of Conduct (CoC) bis Ende 2014 beigetreten sind haben sich damit verpflichtet, dem Datenschutzkodex des GDV innerhalb von 3 Jahren gerecht zu werden.

    Mit den neuen Verhaltensregeln wird transparent, was von der Antragstellung bis zur Schadenregulierung mit personenbezogenen Daten geschieht.

    Lernen Sie wie Informatica die Anforderungen aus dem CoC (Anonymisierung für sensitive Daten in Produktion sowie Test & Entwicklung) umsetzt und gleichzeitig Ihr Testdatenmanagement modernisieren kann.

    Da gemäß BSDSG als auch neuester EU-Novelle Datenschutz ein branchenübergreifendes Thema ist, sind alle Interessenten herzlich zu diesem Webinar eingeladen, die direkt (z.B. Datenschützer) oder indirekt (z.B. Test-Manager, Enterprise Architekten) mit dem Thema konfrontiert werden.

    Unternehmensweiter Datenschutz vom Marktführer – seien sie dabei !
  • Large enterprises want to use all the data they can get to earn the trust and the dollars of their customers. At the same time, they must secure this data, which is increasingly the target of sophisticated cyber-attacks. Traditional triple A (access, authentication and audit) security solutions are no longer sufficient-data-centric security must be added to the mix. In this webinar, join Stratecast | Frost & Sullivan, HP Security Voltage and (ISC)2 on July 16, 2015 at 1:00PM Eastern for an examination of ICT technology trends and business policies that have brought us to this point and how format preserving encryption can be used to protect data at rest, in motion and in use.
  • RNAi screening has made it possible to identify new genes, or gene networks, that are involved in a wide vari¬ety of biological processes, including assays relevant to signal transduction, cell viability, cell morphology, protein localization and function, drug resistance, and responses of host cells to pathogens. As such, RNAi continues to help us gain critical insights into the mechanisms underlying human disease and accelerate the development of treatments for cancer and a host of other disorders. The intersection between RNAi screening and complementary approaches such as CRISPR-Cas9-mediated genome editing has opened up new opportunities for assay development, screening and validation. The successful implementation of genome-editing technologies in several species suggests this will serve as an important and relevant tool for validation studies in numerous cell lines and model systems. Additionally, RNAi rescue experiments using LentiORFs serve an important role in further validating and boosting confidence of screened hits. As we continue to develop new strategies to improve genome-wide RNAi screening and validation, the significance of RNAi as a research tool will remain for many years to come.
  • Channel
  • Channel profile
  • The New Age of Regenerative Medicine – Why Stem Cell Therapy? Recorded: Jul 28 2015 59 mins
    Jane Andrews, Ph.D ; Sanjeev Kumar ; Rhenu Bhuller
    Cell therapy is the fastest growing segment of regenerative medicine. Cell therapy is comprised of immune cell therapy and stem cell therapy, with stem cell therapy making up the largest part of this market: it is estimated that the global stem cell therapy market will reach $40 billion by 2020 and $180 billion by 2030.

    Many factors determine the rate at which the stem cell therapy market advances. It is driven by the success of stem cell treatments in curing life-threatening diseases such as cancer, heart diseases and neuromuscular diseases in the worlds aging populations. In contrast, stem cell market growth rate is hindered by manufacturing and regulatory concerns. For example, if only 20% of the 318 global late stage clinical trials are approved for release on the market, there will not be enough stem cell therapy manufacturing facilities to produce the 64 resulting products. This is due, in part, to funding concerns, the high cost of build-out as well as cGMP compliance, standardization of production processes, and ever changing industry regulations.

    Join us as we discuss these and other key topics.
  • Pharmaceuticals Market Briefing Recorded: Jun 26 2015 62 mins
    Rathanesh Ramasundram
    The Asia Pacific is the third largest pharmaceutical market in the world after North America and Europe, with generics being the major driver for the pharmaceutical industry in this region, aided by factors such as the aging population and impending expiry of patented drugs. It is a necessity for pharmaceutical companies to be aware of the key trends in the APAC generics market and maximise the market opportunities in order to remain relevant.

    In today’s rapidly evolving business landscape, pharmaceutical companies are also starting to realise the importance of the customer experience as a key differentiator. With a gradual shift from product to the customer, the pharmaceutical industry needs to keep up with other industries in terms of providing the perfect digital customer experience. A well-executed digital strategy is essential for today’s pharmaceutical companies to better connect with their clients.

    Join us as we discuss these and other key topics.
  • 2015 Healthcare Industry Outlook Recorded: Jan 27 2015 55 mins
    Reenita Das and Venkat Rajan
    The healthcare industry is entangled in a transitory phase where therapeutics, products and services are sold into traditional care settings that are saturated and exhausted. Yet, the opportunities for new services and care, like ambulatory, mobile, and home care, lack the appropriate level of maturity to provide robust revenue streams.

    As a result, Frost & Sullivan’s experts are predicting a year full of big disruptions, transformations and innovations. What’s in store for pharmaceuticals, biotechnology, medical devices, medical imaging, mobile health, healthcare IT, etc.? This briefing will provide an in-depth discussion examining at what degree we can expect the impact to take hold and transpire over the upcoming year.

    Attend this webinar to discover:
    •Insightful analyst predictions and probative analysis of the global healthcare industry in 2015.
    •Key strategies and initiatives executed by companies and organizations to capture opportunities for solutions in health, wellness, and prevention.
    •Track the progress of key macro level industry trends and their projected milestones for 2015.
    •An interactive Q&A session with Frost & Sullivan’s senior industry thought leaders.
  • 2015 Asia Pacific Healthcare Outlook Recorded: Jan 16 2015 110 mins
    Rhenu Bhuller, Natasha Gulati, Dr.Milind Sabnis
    Public and private sector initiatives continue to transform the Healthcare industry in the Asia-Pacific - and their impact is likely to be seen in the coming months. For example, improving access to quality and affordable healthcare is a major goal of governments across the region, and a focus for reform efforts in many countries.

    Frost & Sullivan provides in-depth insights on how impending regulations, ethics and compliance reforms, emerging business and service models and industry partnerships will impact healthcare in the region

    Join us as we examine key trends for 2015 and beyond and discuss their impact on pharmaceuticals, medical devices, health technology, insurance, healthcare delivery and wellness across Asia-Pacific.
  • The Promise of Integrated Healthcare: Health Information Systems Recorded: Jul 31 2014 54 mins
    Bhargav Rajan, Research Analyst
    Given increasing healthcare consumerism and demand for round-the-clock healthcare delivery, hospitals and providers must upgrade their healthcare IT infrastructure to accommodate patient and provider needs. This briefing will investigate the changing technology landscape in hospitals globally and will specifically focus on how hospitals in North America and Europe are adopting health information systems (HIS).

    Attend this webinar to discover:

    ·Information technology systems in hospitals
    ·Drivers and restraints of HIS
    ·A technology and adoption roadmap of HIS
  • Telecommunication Takes On Healthcare Recorded: May 6 2014 47 mins
    Daniel Ruppar, Natasha Gulati, and Shruthi Parakkal
    Telecommunication companies are increasingly seeking new revenue streams by exploring vertical markets like healthcare. Though traditional telecommunication services have achieved strong penetration in the healthcare industry, more sophisticated solutions are only now starting to generate sustainable returns and have a long way to go in terms of enabling a new-age healthcare system. While the industry presents promising opportunities, few telecommunication service providers have been able to establish successful business models in this space.
    Frost & Sullivan will present insights on critical factors that companies overlook while developing their healthcare strategy.

    Attend this webinar to discover:

    •Key success factors necessary for all telecommunication companies establishing a healthcare presence
    •Emerging business models that promise sustainable revenue for leading telecommunication companies in healthcare
  • Healthcare 2020: Disrupt, Transform and Collapse Recorded: Mar 19 2014 57 mins
    Reenita Das, Siddharth Saha, Venkat Rajan, and Natasha Gulati
    Attend this webinar to discover:

    •Changes to healthcare delivery: hospitals of the future, aging in place, cost of care innovations
    •Role of the patient and consumer influence
    •Role of emerging regions as a consumer and competitor
    •Novel industry business models
    •Key disruptive technologies
  • Asia-Pacific Healthcare Outlook 2014 Recorded: Feb 13 2014 44 mins
    Rhenu Bhuller, Reenita Das, and Natasha Gulatii
    Frost & Sullivan will provide an outlook for healthcare in 2014 with detailed insights on the regulatory challenges, investment trends, innovation temperature and emerging business models in the Asia-Pacific Healthcare market.
  • Technology Breakthroughs in Sleep Apnea Recorded: Nov 21 2013 48 mins
    Saju John Mathew, Industry Analyst
    Attend this webinar to discover:

    • Insight into the sleep apneic industry
    • Drivers and restraints of the industry
    • Current trends and technology roadmap
  • Are Biosimilars the Road to Certain Success or a High-Risk Venture? Recorded: Oct 17 2013 45 mins
    Deborah Toscano, Senior Industry Analyst
    Why You Should Attend:

    • Discover the issues involved in regulatory and payer acceptance of biosimilars in the US
    • Learn how biosimilars are forecast to penetrate the various biopharmaceutical segments and therapeutic areas
    • Understand the potential risks and rewards of this market
    • Gain insight into the competitive environment and the potential US market leaders
    • Identify the factors with the potential to impact the uptake of biosimilars
  • 3-D Printing - Healthcare in a Printed World Recorded: Oct 7 2013 34 mins
    Darshana De, Industry Analyst
    With the current advancements in 3-D printing technologies for customized fabrication of complex polymer-based objects, there is much focus on adapting the 3-D printing technologies for healthcare applications. This has aroused interests in engineering bioprinting devices that can develop 3-D structures and at the same time accommodate the incorporation of living cells.

    - The session will discuss the following:
    - The potential of 3-D printing in healthcareD
    - Drivers and challenges for the technology
    - Impact of 3-D printing, scenario melling
  • Next Generation Imaging Informatics: Identifying Unmet Needs in Radiology Recorded: Oct 2 2013 47 mins
    Rhenu Bhuller, Mark Dougan
    GE sponsored whitepaper research from Frost & Sullivan finds that the most severe obstacle in the daily work of Australian radiologists is data fragmentation and inefficient information management. Lack of interoperability and inadequate communication amongst systems and departments lead to critical time pressures that impact the radiologists’ productivity.
  • New Era in Revenue Cycle Management Emerges as Healthcare Transforms Recorded: Sep 24 2013 58 mins
    Nancy Fabozzi, Healthcare Principal Analyst
    Why You Should Attend:

    • Learn what RCM is and why it is so important

    • Discover why healthcare providers are increasing their focus on technology solutions to improve end-to-end RCM

    • Review the major disruptive trends in the industry

    • Find out how next-generation technology solutions will help providers streamline and enhance their RCM process
  • Effective Growth Strategies for the Soaring Russian Healthcare Market Recorded: Sep 4 2013 54 mins
    Research Director Siddharth Saha and Senior Consultant Vitaliy Lehkyy
    Attendees will learn about challenges in this diverse marker and pitfalls to avoid; hear about best practices and success stories; and gain insights on effective strategies.

    Why Should You Attend:
    - Learn best practices and what works and does not from the trenches
    - Discover lessons to take from India and China and adopt to Russia
    - Assess specific market opportunities for growth
  • Next Generation Imaging Informatics: Identifying Unmet Needs in Radiology Recorded: Aug 29 2013 49 mins
    Rhenu Bhuller, Mark Dougan
    GE sponsored whitepaper research from Frost & Sullivan finds that the most severe obstacle in the daily work of Australian radiologists is data fragmentation and inefficient information management. Lack of interoperability and inadequate communication amongst systems and departments lead to critical time pressures that impact the radiologists’ productivity.
  • Outlook of Iran and Azerbaijan Healthcare Markets Recorded: Aug 1 2013 36 mins
    Hilal Cura, Research Analyst and Uldouz Berenjforoush, Research Analyst
    This analyst briefing will discuss:

    - High government focus on growth of the healthcare industry and implementing healthcare reforms
    - Growing economies, with their oil-rich and wealthy position
    - Increasing awareness and affluence among their population for healthcare consumption
  • Original Drugs Pave the Way for Follow-on-Biologics Recorded: Jun 18 2013 29 mins
    Sandhya Kamath, Technical Insights Manager
    With the impending patent expiries of biologic drugs, there is a huge market potential for subsequent entry biologics. A strong integration of R&D and marketing is key to success, and this briefing will highlight the technology advancements.

    Why you should attend:
    ·Learn about the growth of follow-on-biologics
    ·Identify the drivers and restraints
    ·Discuss trends in technology development
  • Will BRIC be the Savior for the Life Sciences and Medical Devices Sector? Recorded: May 15 2013 59 mins
    Reenita Das, Eduardo Golisano, Sandeep Sinha, Xuchao Glenn Hou, and Siddharth Saha
    Attend this webinar to discover:

    ·Insight from BRIC healthcare leaders as they share field experiences and best practices gathered through hundreds of successful cases
    ·Common obstacles international companies must overcome in these regions
    ·How to exploit the hidden potential of BRIC countries
    ·Tactics to adjust strategy to successfully penetrate BRIC markets
    ·The top 10 technologies and products expected to drive growth in these regions
  • Global Trends and Transitions Shaping the Future of Medical Imaging Equipment Recorded: Apr 25 2013 39 mins
    Roberto Aranibar, Medical imaging Industry Analyst
    Attend this webinar to discover:

    •Evaluate market potential for basic and advanced medical imaging modalities
    •Learn about important market characteristics and trends
    •Identify opportunities for growth in medical imaging equipment markets within each region of the world
    •Consider factors affecting market growth internationally
  • APAC Market Poised for Electronic Medical Record Growth Recorded: Apr 25 2013 32 mins
    Natasha Gulati, Industry Analyst, Healthcare
    As the healthcare industry across APAC moves toward digitization, electronic health information exchange becomes a stepping stone to success. Governments, non-profit entities and the private sector are aggressively investing in Electronic Medical Record (EMR) and Electronic Health Record (EHR) systems. This Frost & Sullivan briefing presents a comprehensive analysis of the EMR and EHR markets in APAC, with special focus on emerging opportunities in the region.

    Why You Should Attend:
    - Learn about the rapidly developing EMR and EHR markets in APAC
    - Understand key market drivers and restraints
    - Identify leading market participants and their role in the competitive environment
    - Recognize areas of growth within this space
Frost & Sullivan GIL Webcast Series
Our Helthcare webcasts cover Connected Health, Life Sciences and Advanced Medical Technologies to help you to better understand buyer-seller dynamics as the healthcare system transitions to digital information, the pace at which new and innovative medical devices and systems are being adopted and getting embedded into the typical clinical pathway, both in mature and emerging markets, and enables you to bring clarity to pharmaceutical/biotechnology, in-vitro diagnostics and life science research tools market decisions and implementation tactics.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Asia Pacific Healthcare Outlook 2012-2015: What comes next..
  • Live at: Dec 8 2011 3:15 am
  • Presented by: Reenita Das, Senior Vice President Healthcare and Lifesciences, Frost & Sullivan
  • From:
Your email has been sent.
or close
You must be logged in to email this